Position in CRVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$107,045,189
+$2,221,152 QoQ
Shares Held
7,165,006
0.0% QoQ
Ownership
8.52%
of shares outstanding
% of Portfolio
2.12%
of 13F equity value
Holder Rank
#1
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. CRVS ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $630,516,329 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
6,776,632 | $343,914,074 | |
| 3 | MBX |
MBX Biosciences, Inc.
|
3,428,736 | $189,266,227 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
2,209,400 | $118,578,498 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
2,555,877 | $112,433,029 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
This page
|
7,165,006 | $107,045,189 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
3,027,328 | $105,169,374 | |
| 8 | ARGX |
Argenx SE
|
92,880 | $86,171,277 |
All Filings in CRVS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $107,045,189 | 7,165,006 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $104,824,037 | 7,165,006 | Shares | Sole | 2026-05-15 | |
| 2026-01-23 | $216,088,184 | 8,609,091 | Shares | Sole | 2026-01-27 | |
| 2025-12-31 | $55,170,546 | 7,165,006 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $52,806,094 | 7,165,006 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,660,024 | 7,165,006 | Shares | Sole | 2025-08-14 | |
| 2025-05-12 | $39,679,890 | 9,785,423 | Shares | Sole | 2025-05-14 | |
| 2025-04-29 | $35,423,231 | 9,785,423 | Shares | Sole | 2025-05-01 | |
| 2025-03-31 | $22,080,819 | 6,943,654 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,148,548 | 6,943,654 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $36,662,493 | 6,943,654 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,637,450 | 6,943,654 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,359,704 | 6,943,654 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,220,831 | 6,943,654 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,137,734 | 6,943,654 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $15,900,967 | 6,943,654 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,318,725 | 6,943,654 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,902,105 | 6,943,654 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,686,852 | 6,943,654 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,874,217 | 6,943,654 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,387,592 | 6,943,654 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,734,206 | 6,943,654 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $33,607,285 | 6,943,654 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $21,502,305 | 8,053,298 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $24,804,157 | 8,053,298 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $24,092,599 | 6,767,584 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $27,138,011 | 6,767,584 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $18,407,828 | 6,767,584 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $14,279,602 | 6,767,584 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||